Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- François Ringeisen, MD
Polyphor Ltd.
Study Director - Javier Cortes, MD
IOB and VHIO; Spain
Principal Investigator - Peter A Kaufman, MD
UVM medical center; USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro Polivalente de Asistencia E Investigación Clínica - Cer San Juan
San Juan, Buenos Aires, Argentina
- Centro de Investigación Clínica - Clínica Viedma
Viedma, Río Negro Province, Argentina
- Sanatorio Parque de Rosario
Rosario, Santa Fe Province, Argentina
- Caipo Centro Para la Atención Integral del Paciente Oncológico
San Miguel de Tucumán, Argentina
- Grand Hopital de Charleroi Asbl
Charleroi, Hainaut, Belgium
- Uz Antwerpen
Antwerp, Belgium
- Chirec Centre Hospitalier Interregional Edith Cavell
Brussels, Belgium
- Uz Gent
Ghent, Belgium
- Chu de Liège
Liège, Belgium
- Centro de Oncologia Da Bahia
Bahia, Brazil
- Universidade de Caxias Do Sul (ipcem-Ucs)
Caxias do Sul, Brazil
- Liga Paranaense de Combate Ao Cancer - Hospital Erasto Gaertner
Curitiba, Brazil
- Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (pucrs)
Porto Alegre, Brazil
- Inca Instituto Nacional de Cancer
Rio de Janeiro, Brazil
- Hospital de Base Da Faculdade de Medicina de São José Do Rio Preto
São José do Rio Preto, Brazil
- Clinica de Pesquisas E Centro de Estudos Oncologia Ginecologica E Mamaria Ltda
São Paulo, Brazil
- Multiscan S.R.O - Onkologická Ambulance
Hořovice, Czechia
- Fakultni Nemocnice Hradec Kralove
Hradec Králové, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer Rhône Alpes
Lyon, France
- Institut de Cancérologie de L'Ouest
Saint-Herblain, France
- Edog - Institut Claudius Regaud - Ppds
Toulouse, France
- Ospedale San Raffaele S.R.L. - Ppds
Milan, Lombardy, Italy
- Asst Di Monza - Azienda Ospedaliera San Gerardo
Monza, Milano, Italy
- Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi
Bologna, Italy
- Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele
Catania, Italy
- Azienda Ospedaliera Universitaria - Università Degli Studi Della Campania "luigi Vanvitelli"
Naples, Italy
- Llc Evimed
Chelyabinsk, Russia
- Krasnoyarsk Regional Oncology Center N.A. A.I. Kryzhanovskiy
Krasnoyarsk, Russia
- Medical Center Tonus
Nizhny Novgorod, Russia
- Budgetary Healthcare Institution of the Omsk Region "clinical Oncology Dispensary"
Omsk, Russia
- Evromedservis Lcc
Pushkin, Russia
- Mordovia State University
Saransk, Russia
- Research Oncology Institute of Tomsk Scientific Center
Tomsk, Russia
- Volgograd Regional Clinical Oncology Dispensary
Volgograd, Russia
- National Cancer Center
Goyang-si, South Korea
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Ulsan University Hospital
Ulsan, South Korea
- Hospital Universitario Virgen Macarena
Seville, Andalusia, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 May 2019
- Primary completion
- 19 Oct 2021
- Completion
- 19 Oct 2021
- Last update posted
- 1 Nov 2023
- Registered enrollment
- 432
- Registry id
- NCT03786094
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.